Literature DB >> 7054229

Normal cortical bone mass in patients after long term coumadin therapy.

L D Piro, M P Whyte, W A Murphy, S J Birge.   

Abstract

Clinical delineation of the warfarin embryopathy and the recent discovery of osteocalcin (a vitamin K-dependent bone protein) suggest that coumadin therapy could adversely affect the skeleton. Using bone densitometry and metacarpal cortical width measurement, we found normal cortical bone mass in 17 adults receiving long term coumadin therapy.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7054229     DOI: 10.1210/jcem-54-2-470

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  3 in total

Review 1.  Medication-induced osteoporosis: screening and treatment strategies.

Authors:  Keshav Panday; Amitha Gona; Mary Beth Humphrey
Journal:  Ther Adv Musculoskelet Dis       Date:  2014-10       Impact factor: 5.346

2.  Single-point assessment of warfarin use and risk of osteoporosis in elderly men.

Authors:  Claudine Woo; Linda L Chang; Susan K Ewing; Douglas C Bauer
Journal:  J Am Geriatr Soc       Date:  2008-06-10       Impact factor: 5.562

Review 3.  Beyond deficiency: potential benefits of increased intakes of vitamin K for bone and vascular health.

Authors:  Cees Vermeer; Martin J Shearer; Armin Zittermann; Caroline Bolton-Smith; Pawel Szulc; Stephen Hodges; Paul Walter; Walter Rambeck; Elisabeth Stöcklin; Peter Weber
Journal:  Eur J Nutr       Date:  2004-02-05       Impact factor: 5.614

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.